General Name ：Recombinant Human Interferon α1b  for Injection

      Clinical Application ：Treatment of viral infection and some malignant tumors.  Common application such as:

      Infectious Disease / Liver Diseases: Chronic hepatitis B and chronic hepatitis c, epidemic hemorrhagic fever

      Pediatrics: Viral pneumonia, bronchiolitis, hand, foot and mouth disease, viral enteritis, chronic hepatitis B, chronic hepatitis C, Infectious mononucleosis, upper respiratory tract infection, viral encephalitis. Chicken pox and measles

      Oncology: Hairy cell leukemia, chronic myeloid leukemia, Melanoma, lymphoma

      Skin: condyloma acuminate, skin herpes simplex, herpes zoster

      Gynecology: chronic cervicitis, cervical erosion

      Other: viral myocarditis

 

Product features:

1. Good Safety –   Originates from health Chinese people with mild adverse reaction and low  nAb rate

2. High antiviral efficacy  –  Higher expression of  STAT1 signaling  than other subtypes

3. Strong immunomodulation –  Increasing MHC II expression of mononuclear cells  and  phagocytosis  function

4. High quality –  Higher purity and  less endotoxin comparing with national standard

Awards & Recognition:

Class A New Drug, national key new product, Beijing major scientific and technological achievements promotion program